Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps.

Traditionally, asthma-practice guidelines have focused on optimizing lung function and the US FDA has required increases in lung function and reduction of exacerbation as primary outcomes in ...

Spirometry is one of the fundamental measures of asthma control; it provides an objective measure of airflow limitation caused by smooth-muscle contraction or structural changes.

Steroid resistant asthma can be combatted with antibody therapy, but delivery and off-target effects are a concern. Here, the authors report on the co-delivery of thymic stromal lymphopoietin ...